Workflow
Moderna(MRNA) - 2024 Q1 - Earnings Call Presentation

Forward-looking statements and disclaimer 2 Financials Jamey Mock, CFO usiness Revie | --- | --- | --- | --- | --- | --- | |--------------------------|-------|-------|-------|-------|-------| | | | | | | | | vaccines | | | | | | | addressing | | | | | | | respiratory and | | | | | | | latent + other pathogens | | | | | | | | | | | | | © 2024 Moderna, Inc. All rights reserved. Financial figures in this presentation as of, and for the quarterly periods ended, March 31, 2024, and March 31, 2023, are unaudited. ...